Nguyen Teri D, Abrey Lauren E
Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
Hematol Oncol Clin North Am. 2007 Apr;21(2):369-88. doi: 10.1016/j.hoc.2007.03.009.
Brain metastases from breast cancer are a common complication of the disease and alter the management of patients more than any other site of distant progression. Certain subgroups of patients are at high risk for developing CNS disease, warranting targeted research and perhaps screening for occult disease. Data from studies that include other solid tumor histologies provide the bulk of supporting evidence for the use of therapies, such as steroids, antiepileptic drugs, surgery, and radiation. However, there are several issues specific to brain metastases from breast cancer illustrating that this disease should be considered pathophysiologically distinct, and future research should be tailored accordingly.
乳腺癌脑转移是该疾病常见的并发症,相较于其他任何远处转移部位,它对患者治疗方案的改变更大。某些亚组患者发生中枢神经系统疾病的风险较高,这使得针对性研究以及或许对隐匿性疾病进行筛查成为必要。包含其他实体瘤组织学类型的研究数据为使用如类固醇、抗癫痫药物、手术及放疗等治疗方法提供了大量支持证据。然而,乳腺癌脑转移存在几个特定问题,表明这种疾病在病理生理学上应被视为有别于其他疾病,未来的研究应据此进行调整。